HOME >> BIOLOGY >> NEWS
Application of Genomatix in silico methods reveals novel cancer associated genes

Munich, March 19, 2007>> Genomatix Software GmbH, an in silico systems biology company with headquarter in Munich (Germany), released today that researcher in Dublin, Ireland and Boston, U.S.A. identified novel cancer associated genes, based on strategies and products developed and promoted by Genomatix. Experimental verification by siRNA knock-down and RT-PCR confirmed the in silico results.

"I am delighted that an ever increasing number of scientists proof the validity of our concepts and experience the value of our integrated approach. This excellent work, carried out by researchers at The Conway Institute of the University College, Dublin, The Mater Misericordiae University Hospital in Dublin and The Beth Israel Deaconess Medical Center in Boston demonstrates a straightforward strategy from computer analysis to experimental verification.", says Klaus May, Chief Business Officer at Genomatix. He continues:" Two years ago we introduced our own concepts of an annotation and biology driven microarray analysis pipeline, and were heavily contested in the beginning. Today it is so rewarding to our scientists and developers to see the impact of our own ideas and research to cutting edge science of today."


'"/>

Contact: Olivia Prazeres da Costa
dacosta@genomatix.de
49-895-997-660
Genomatix Software GmbH
19-Mar-2007


Page: 1

Related biology news :

1. Porous Media and its Applications in Science, Engineering and Industry
2. Advances in Forest Threat Assessment: Applications to Forest and Rangeland Management
3. Nanostructured Materials: Environmental, Energy and Sensing Applications
4. Genomatix expands operations in North America
5. Genomatix and Molecular Connections form strategic partnership
6. Genomatix wins BioChance grant worth $1.6 million
7. Genomatix appoints distributor for the growing Chinese market
8. MatBase -- A new transcription factor knowledge base released by Genomatix
9. The Center of Nutrigenomics of the TU Munich licences Genomatix Microarray Analysis Pipeline
10. Bayer HealthCare licenses Genomatix for microarray analysis
11. Genomatix technology facilitates de novo identification of new renal disease associated genes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. ... with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. ... supply chain for more than 10 years. Early in the COVID-19 crisis, we ...
(Date:7/31/2020)... ... 30, 2020 , ... Justin Zamirowski to lead upcoming launches ... focus on Type 2 diabetes and associated comorbidities. , Justin brings over 20 ... classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ efforts ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device ... The study reported that the Neoasis™ device attenuated the alarm sounds from patient ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions its ... MediVet Biologics since its formation in 2016, the company is relaunching itself under the ... on its base of innovative therapies for osteoarthritis and cancer. , ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... radar transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and ... can drive one or two switches in a push-pull configuration; yielding fast fall ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... eSource has ... inefficiencies. This webinar will cover the history of eSource, the reasons it did not ... EMR/EHR to wearables, to site source, the industry is moving towards capturing data electronically ...
(Date:7/22/2020)... (PRWEB) , ... July 22, 2020 , ... Join experts ... John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... the regulating body in China for drugs and medical devices. Specifically, for medical devices, ...
Breaking Biology Technology:
Cached News: